Chart-Typ:
Zeitraum:
| PacBio Announces the Appointment of Chris Gibson to the Board of Directors | MENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher... ► Artikel lesen |
| PacBio Announces Fourth Quarter and Full Year 2025 Financial Results | MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2025. Fourth quarter and full year... ► Artikel lesen |
| PacBio Completes Sale of Short-Read Sequencing Assets | MENLO PARK, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of... ► Artikel lesen |
| PONY AI Inc. Scales with 160% Robotaxi Revenues Growth YoY and 500%+ Fare-Charging Revenues Surge YoY in Q4, Targeting Deployment in 20+ Cities by Year-End | Strengthening revenue trajectory - Robotaxi revenues rose by 160% year-over-year in Q4, with fare-charging revenues surging by over 500%.Accelerating fleet and geographic expansion - Robotaxi scaling... ► Artikel lesen |
| Pony AI Inc.: Verne, Pony.ai, and Uber Partner to Launch Europe's First Commercial Robotaxi Service | The partnership will soon begin in Zagreb, before expanding to additional cities in Europe and beyondZAGREB, Croatia, March 26, 2026 /PRNewswire/ -- Verne, Pony AI Inc. ("Pony.ai") (NASDAQ:... ► Artikel lesen |
| Uber Technologies, Inc.: Verne, Pony.ai, and Uber Partner to Launch Europe's First Commercial Robotaxi Service | The partnership will soon begin in Zagreb, before expanding to additional cities in Europe and beyond
Verne, Pony AI Inc. ("Pony.ai") (NASDAQ: PONY; HKEX: 2026), a global leader in the large-scale... ► Artikel lesen |
| CytomX-Aktie: sharedealsPlus-Highflyer schießt auf +1.835% Kursgewinn | Die Aktie von CytomX Therapeutics gehört weiterhin zu den spektakulärsten Turnaround-Stories im Biotech-Sektor. Seit ihrem Vorjahrestief hat sich der Kurs des sharedealsPlus-Tipps inzwischen um rund... ► Artikel lesen |
| CytomX Therapeutics Inc.: CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update | - Announced Positive Data from Phase 1 Dose Expansion Study of varsetatug masetecan ("Varseta-M") EpCAM PROBODY ADC in Patients with Advanced Colorectal Cancer (CRC) - - FDA interactions targeted... ► Artikel lesen |
| SD-Tipp CytomX: Was tun nach +1.438% in 10 Monaten? | Unsere Aktien-Empfehlung CytomX Therapeutics erlebt derzeit einen außergewöhnlich starken Kursverlauf. Innerhalb kurzer Zeit hat sich das Papier von einem lange übersehenen Small-Cap-Titel zu einem... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CERO THERAPEUTICS HOLDINGS INC finden Sie auf Wallstreet Online.